FOXO3 rs13220810: What Your Genotype Means
The rs13220810 variant is a non-coding genetic change located within the FOXO3 gene. It has been identified in various longitudinal studies as a marker potentially associated with survival into advanced old age.
What each genotype means
Baseline longevity association
This genotype represents the major allele combination at this FOXO3 locus. Research into FOXO3 variants suggests that individuals with this genotype do not carry the specific genetic markers frequently associated with increased survival into advanced old age in various longitudinal studies. Longevity is a complex trait influenced by many genetic and environmental factors, so this result should be viewed as only one small piece of a much larger picture.
This is the most common genotype in many populations, carried by a majority of individuals of European ancestry.
Potential longevity advantage
Carrying one copy of the minor allele at this FOXO3 location may be associated with a modest biological advantage regarding healthy aging. Studies on FOXO3 variants indicate that these markers are linked to the insulin/IGF-1 signaling pathway, which plays a role in cellular maintenance and longevity. This association is statistical in nature and does not guarantee any specific health outcome or lifespan.
This heterozygous genotype is found in a significant portion of the population, appearing in roughly 40-45% of individuals of European ancestry.
Enhanced longevity association
This genotype is homozygous for the minor allele, which has been identified in multiple studies as being more frequent in individuals who survive into advanced old age. Research suggests this variant may influence FOXO3 gene expression or regulation, potentially supporting healthy aging processes. While this association is statistically significant in many cohorts, it remains a complex trait and is not a definitive predictor of individual lifespan.
This genotype is the least common of the three, carried by approximately 1 in 8 to 1 in 10 people of European ancestry.
Understanding the rs13220810 Variant
The rs13220810 variant is a single nucleotide polymorphism (SNP) situated within the FOXO3 gene. Unlike variants that change the protein sequence directly, this SNP is located in a non-coding region, meaning it does not alter the amino acid structure of the FOXO3 protein itself. Instead, researchers investigate whether such non-coding variants influence how the gene is regulated, expressed, or spliced within cells. Because it sits in a region that may affect gene activity, scientists have tracked it in studies focused on human longevity. It is important to note that while this variant is often discussed in the context of aging, it is just one of many genetic factors that contribute to the complex, multi-faceted process of human lifespan.
The Role of the FOXO3 Gene
The FOXO3 gene encodes a transcription factor, which is a protein that helps turn other genes on or off. FOXO3 is part of a highly conserved family of proteins found in many species, from simple organisms like worms to humans. It acts as a critical node in signaling networks that manage cellular stress, energy metabolism, and the cell cycle. By regulating these pathways, FOXO3 helps cells respond to environmental challenges, such as oxidative stress or nutrient deprivation. Because of its central role in maintaining cellular health and homeostasis, researchers have long hypothesized that variations in FOXO3 might influence how individuals age. By modulating these fundamental biological processes, the gene is thought to play a role in protecting cells from age-related decline.
Research and Evidence Strength
The association between FOXO3 variants and longevity has been a subject of significant scientific interest since early studies in the late 2000s. Several longitudinal studies have observed that certain FOXO3 alleles appear more frequently in centenarians and individuals who reach advanced ages compared to the general population. However, the evidence for any single SNP, including rs13220810, remains limited and sometimes inconsistent across different cohorts and ancestries. While some studies have reported statistically significant associations, others have found weaker or no correlation, highlighting the complexity of genetic influences on lifespan. Exceptional longevity is widely considered a polygenic trait, meaning it is likely the result of many different genetic variants acting in concert, rather than the effect of a single gene or SNP.
Population Frequency
The frequency of the rs13220810 variant varies across different human populations. In European populations, the minor allele frequency is approximately 0.35. Because genetic architecture differs significantly between ancestral groups, the prevalence and potential impact of this variant may not be uniform globally. Researchers use large-scale databases like gnomAD to track these frequencies, which helps in understanding how common a variant is within specific genetic backgrounds. It is essential to recognize that population-level statistics describe broad trends and do not predict the health outcomes or lifespan of any specific individual.
Interpreting Your Genetic Information
If you have access to your genetic data, you may see your genotype for rs13220810. It is important to understand that this information is for educational purposes only and cannot be used to predict your personal longevity or health trajectory. Longevity is influenced by a vast array of factors, including environment, lifestyle, diet, and thousands of other genetic variants. There is no medical action, screening, or treatment associated with this variant. If you have concerns about your health or family history of age-related conditions, the most appropriate step is to consult with a qualified healthcare provider or a genetic counselor. They can provide context based on your overall health profile rather than focusing on a single genetic marker.
How common is this variant?
The minor allele frequency for rs13220810 is approximately 0.35 in European populations, though frequencies can vary significantly across different global ancestries.
Frequently asked questions
Does having the 'longevity' allele guarantee I will live to 100?
No. Longevity is a complex trait influenced by thousands of genetic variants, lifestyle choices, and environmental factors. A single genetic variant cannot predict or guarantee a specific lifespan.
Is rs13220810 a diagnostic test for aging?
No. There is no clinical test for aging based on this variant. It is a subject of scientific research, not a tool for medical diagnosis or health prediction.
Should I change my diet based on my FOXO3 genotype?
No. There are no evidence-based dietary or medical recommendations linked to this specific SNP. Always consult with a healthcare professional before making significant changes to your health regimen.
Why do different studies show different results for this gene?
Genetic association studies can vary due to differences in study design, the age and ancestry of the participants, and the complex nature of polygenic traits. This is why scientific consensus requires replication across many diverse populations.
Sources & further reading
Educational information only, last refreshed 10/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs13220810?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FOXO3
Functional non-coding variant in the key longevity regulator FOXO3 contributing to extended survival and healthspan.
Well-characterized non-headline FOXO3 variant associated with healthy aging, lower cardiovascular mortality, and survival beyond age 90.
Common upstream intronic regulatory variant in FOXO3 correlated with human longevity and enhanced resilience against metabolic disease.
An intronic variant in the FOXO3 gene consistently associated with human longevity and survival to extreme old age across multiple ethnic cohorts.
Intronic variant in FOXO3 significantly associated with exceptional longevity and survival to advanced old age, showing allele-dependent enhancer activity.
FOXO3 variant linked to longevity and reduced mortality risk.